Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety Evaluation of Escalating Doses”

337 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 337 results

Early research (Phase 1)Temporarily pausedNCT06739707
What this trial is testing

Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes

Who this might be right for
Healthy Volunteer
Cohen Global, Ltd. 54
Testing effectiveness (Phase 2)Study completedNCT03294798
What this trial is testing

Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient

Who this might be right for
Hepatitis B Virus
Tianjin SinoBiotech Ltd. 11
Early research (Phase 1)Study completedNCT06294301
What this trial is testing

Single and Multiple Doses of LP-005 in Healthy Adult Participants

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Longbio Pharma 68
Early research (Phase 1)Study completedNCT03446053
What this trial is testing

Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers

Who this might be right for
Healthy VolunteersAnti-Bacterial AgentsMethicillin-Resistant Staphylococcus Aureus+1 more
Intron Biotechnology, Inc. 33
Early research (Phase 1)Study completedNCT04583228
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects

Who this might be right for
COVID 19
Hengenix Biotech Inc 32
Testing effectiveness (Phase 2)Study completedNCT03030612
What this trial is testing

ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
OncoVerity, Inc. 38
Testing effectiveness (Phase 2)WithdrawnNCT06570434
What this trial is testing

Phase 1b/2a in SLE With Budoputug

Who this might be right for
Systemic Lupus ErythematosusSLEB Cells
Tenet Medicines
Early research (Phase 1)Study completedNCT00964262
What this trial is testing

Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide

Who this might be right for
Type 2 Diabetes Mellitus
Peptron, Inc. 34
Early research (Phase 1)Ended earlyNCT02610062
What this trial is testing

Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Astellas Pharma Global Development, Inc. 23
Early research (Phase 1)Ended earlyNCT05144334
What this trial is testing

BTX-1188 in Subjects With Advanced Malignancies

Who this might be right for
Advanced Solid TumorNon Hodgkin LymphomaAcute Myeloid Leukemia
Biotheryx, Inc. 8
Early research (Phase 1)Study completedNCT03189017
What this trial is testing

A Phase I Study of ICP-022 in Healthy Subjects

Who this might be right for
Systemic Lupus ErythematosusRheumatoid Arthritis
Innocare Pharma Australia Pty Ltd 64
Testing effectiveness (Phase 2)Study completedNCT04117711
What this trial is testing

Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia

Who this might be right for
Classic Galactosemia
Applied Therapeutics, Inc. 114
Testing effectiveness (Phase 2)Study completedNCT00320021
What this trial is testing

Effect of Pyridorin in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
BioStratum 80
Early research (Phase 1)Study completedNCT04999527
What this trial is testing

Study to Evaluate the Safety, Tolerability, PK and PD of DISC-0974 in Healthy Subjects

Who this might be right for
Healthy Volunteer
Disc Medicine, Inc 42
Early research (Phase 1)Study completedNCT00616733
What this trial is testing

12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Daiichi Sankyo 25
Early research (Phase 1)Study completedNCT00721812
What this trial is testing

A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686

Who this might be right for
Inflammatory Bowel Diseases
GlaxoSmithKline 87
Early research (Phase 1)Ended earlyNCT01270906
What this trial is testing

Safety of CHIR-258 (TKI258) in Advanced Solid Tumors

Who this might be right for
NeoplasmsCancerTumors
Novartis Pharmaceuticals 35
Early research (Phase 1)Study completedNCT01858935
What this trial is testing

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ND-L02-s0201 Injection in Normal Healthy Subjects

Who this might be right for
Healthy
Bristol-Myers Squibb 56
Early research (Phase 1)Study completedNCT04519073
What this trial is testing

Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus

Who this might be right for
Acute Bronchiolitis Due to Respiratory Syncytial Virus
Virometix 60
Early research (Phase 1)Study completedNCT00848939
What this trial is testing

Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
United Therapeutics 28
Next Page